CAMP pathway and pituitary tumorigenesis

Annales d'Endocrinologie

Volumn 73, Issue 2, 2012, Pages 73-75

  Lania, Andrea ^a   Mantovani, Giovanna ^a   Spada, Anna ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; GROWTH HORMONE; NEUROHORMONE;

ALPHA CHAIN; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; ENDOCRINE CELL; ENZYME ACTIVATION; GENE MUTATION; GENETIC ANALYSIS; GNAS GENE; GROWTH HORMONE SECRETING ADENOMA; GROWTH HORMONE SECRETING CELL; HORMONE RELEASE; HUMAN; HYPOPHYSIS FUNCTION; HYPOPHYSIS TUMOR; MOLECULAR INTERACTION; PROTEIN FAMILY; REGULATORY MECHANISM;

ADENOMA; CELL TRANSFORMATION, NEOPLASTIC; CYCLIC AMP; HUMANS; PITUITARY GLAND; PITUITARY NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84860915485     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2012.03.027     Document Type: Article

References (12)

1. Pertuit M., Barlier A., Enjalbert A., Gérard C. Signalling pathway alterations in pituitary adenomas: involvement of Gsalpha, cAMP and mitogen-activated protein kinases. J Neuroendocrinol 2009, 21:869-877.
2. Mantovani G., Bondioni S., Ferrero S., Gamba B., Ferrante E., Peverelli E., et al. Effect of cyclic adenosine 3',5' monophosphate/protein kinase a pathway on markers of cell proliferation in non-functioning pituitary adenomas. J Clin Endocrinol Metab 2005, 90(12):6721-6724.
3. Landis C., Masters S.B., Spada A., Pace A.M., Bourne H.R., Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989, 340:692-696.
4. Spada A., Lania A., Mantovani G. Hormonal signaling and pituitary adenomas. Neuroendocrinology 2007, 85:101-109.
5. Kirschner L.S., Carney J.A., Pack S.D., Taymans S.E., Giatzakis C., Cho Y.S., et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000, 26:89-92.
6. Lania A.G., Mantovani G., Ferrero S., Pellegrini C., Bondioni S., Peverelli E., et al. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Res 2004, 15(64):9193-9198.
7. Romano D., Magalon K., Ciampini A., Talet C., Enjalbert A., Gerard C. Differential involvement of the Ras and Rap1 small GTPases in vasoactive intestinal and pituitary adenylyl cyclase activating polypeptides control of the prolactin gene. J Biol Chem 2003, 278:51386-51394.
8. Ben-Shlomo A., Melmed S. Pituitary somatostatin receptor signaling. Trends Endocrinol Metab 2010, 21(3):123-133.
9. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011, 63(1):182-217.
10. Peverelli E., Mantovani G., Calebiro D., Doni A., Bondioni S., Lania A., et al. The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation. Mol Endocrinol 2008, 22(3):676-688.
11. Peverelli E., Lania A.G., Mantovani G., Beck-Peccoz P., Spada A. Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop. Endocrinology 2009, 150(7):3169-3176.
12. Peverelli E., Mantovani G., Vitali E., Elli F.M., Olgiati L., Ferrero S., et al. Filamin A is essential for dopamine D2 receptor expression and signaling in tumorous lactotrophs. J Clin Endocrinol Metab 2012, 97(3):967-977.